{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:09:01Z","timestamp":1750910941707,"version":"3.41.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,25]]},"DOI":"10.7759\/cureus.86752","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:19:43Z","timestamp":1750879183000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Dietary Intake of Advanced Glycation End Products on Metabolic Parameters and Anthropometric Measurements in Adults"],"prefix":"10.7759","author":[{"given":"Ayfer","family":"Beyaz Coskun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa A","year":"2022","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska AM, Kozio\u0142kiewicz M. Advanced glycation end-products (AGEs): Formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022, 11:10.3390\/cells11081312","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10091848","article-title":"Advanced glycation end products in health and disease","volume":"10","author":"Reddy VP","year":"2022","unstructured":"Reddy VP, Aryal P, Darkwah EK. Advanced glycation end products in health and disease. Microorganisms. 2022, 10:10.3390\/microorganisms10091848","journal-title":"Microorganisms"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.7b00882","article-title":"Control of Maillard reactions in foods: Strategies and chemical mechanisms","volume":"65","author":"Lund MN","year":"2017","unstructured":"Lund MN, Ray CA. Control of Maillard reactions in foods: Strategies and chemical mechanisms. J Agric Food Chem. 2017, 65:4537-52. 10.1021\/acs.jafc.7b00882","journal-title":"J Agric Food Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2015.06.049","article-title":"Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database","volume":"190","author":"Scheijen JL","year":"2016","unstructured":"Scheijen JL, Clevers E, Engelen L, Dagnelie PC, Brouns F, Stehouwer CD, Schalkwijk CG. Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database. Food Chem. 2016, 190:1145-50. 10.1016\/j.foodchem.2015.06.049","journal-title":"Food Chem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/nu14193982","article-title":"Accumulation of advanced glycation end-products in the body and dietary habits","volume":"14","author":"Zawada A","year":"2022","unstructured":"Zawada A, Machowiak A, Rychter AM, Ratajczak AE, Szymczak-Tomczak A, Dobrowolska A, Krela-Ka\u017amierczak I. Accumulation of advanced glycation end-products in the body and dietary habits. Nutrients. 2022, 14:10.3390\/nu14193982","journal-title":"Nutrients"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-008-0071-4","article-title":"Determination of Nepsilon-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry","volume":"36","author":"Assar SH","year":"2009","unstructured":"Assar SH, Moloney C, Lima M, Magee R, Ames JM. Determination of Nepsilon-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids. 2009, 36:317-26. 10.1007\/s00726-008-0071-4","journal-title":"Amino Acids"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200500249","article-title":"Study on fluorescence of Maillard reaction compounds in breakfast cereals","volume":"50","author":"Delgado-Andrade C","year":"2006","unstructured":"Delgado-Andrade C, Rufi\u00e1n-Henares JA, Morales FJ. Study on fluorescence of Maillard reaction compounds in breakfast cereals. Mol Nutr Food Res. 2006, 50:799-804. 10.1002\/mnfr.200500249","journal-title":"Mol Nutr Food Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00591.2009","article-title":"Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy","volume":"298","author":"Tan AL","year":"2010","unstructured":"Tan AL, Sourris KC, Harcourt BE, et al.. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2010, 298:F763-70. 10.1152\/ajprenal.00591.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri J","year":"2010","unstructured":"Uribarri J, Woodruff S, Goodman S, et al.. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010, 110:911-6.e12. 10.1016\/j.jada.2010.03.018","journal-title":"J Am Diet Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1023\/B:REMD.0000032406.84813.f6","article-title":"Glycoxidation and diabetic complications: modern lessons and a warning?","volume":"5","author":"Vlassara H","year":"2004","unstructured":"Vlassara H, Uribarri J. Glycoxidation and diabetic complications: modern lessons and a warning?. Rev Endocr Metab Disord. 2004, 5:181-8. 10.1023\/B:REMD.0000032406.84813.f6","journal-title":"Rev Endocr Metab Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116186","article-title":"Dicarbonyl stress in diabetic vascular disease","volume":"23","author":"Stratmann B","year":"2022","unstructured":"Stratmann B. Dicarbonyl stress in diabetic vascular disease. Int J Mol Sci. 2022, 23:10.3390\/ijms23116186","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/14791641221085269","article-title":"Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques","volume":"19","author":"Pinto RS","year":"2022","unstructured":"Pinto RS, Ferreira GS, Silvestre GC, et al.. Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques. Diab Vasc Dis Res. 2022, 19:14791641221085269. 10.1177\/14791641221085269","journal-title":"Diab Vasc Dis Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132675","article-title":"Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?","volume":"14","author":"Fotheringham AK","year":"2022","unstructured":"Fotheringham AK, Gallo LA, Borg DJ, Forbes JM. Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?. Nutrients. 2022, 14:10.3390\/nu14132675","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0057","article-title":"Oxidative stress as a major culprit in kidney disease in diabetes","volume":"57","author":"Forbes JM","year":"2008","unstructured":"Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008, 57:1446-54. 10.2337\/db08-0057","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-181272","article-title":"Circulating and extracellular vesicles levels of N-(1-Carboxymethyl)-L-Lysine (CML) differentiate early to moderate Alzheimer\u2019s disease","volume":"69","author":"Haddad M","year":"2019","unstructured":"Haddad M, Perrotte M, Landri S, Lepage A, F\u00fcl\u00f6p T, Ramassamy C. Circulating and extracellular vesicles levels of N-(1-Carboxymethyl)-L-Lysine (CML) differentiate early to moderate Alzheimer\u2019s disease. J Alzheimers Dis. 2019, 69:751-62. 10.3233\/JAD-181272","journal-title":"J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-002-0523-y","article-title":"Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease","volume":"104","author":"Dei R","year":"2002","unstructured":"Dei R, Takeda A, Niwa H, et al.. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol. 2002, 104:113-22. 10.1007\/s00401-002-0523-y","journal-title":"Acta Neuropathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2021-0217","article-title":"A novel multi-target strategy to attenuate the progression of Parkinson's disease by diamine hybrid AGE\/ALE inhibitor","volume":"13","author":"Sasaki NA","year":"2021","unstructured":"Sasaki NA, Sonnet P. A novel multi-target strategy to attenuate the progression of Parkinson's disease by diamine hybrid AGE\/ALE inhibitor. Future Med Chem. 2021, 13:2185-200. 10.4155\/fmc-2021-0217","journal-title":"Future Med Chem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/nu14020363","article-title":"In vitro methodologies to study the role of advanced glycation end products (AGEs) in neurodegeneration","volume":"14","author":"Chrysanthou M","year":"2022","unstructured":"Chrysanthou M, Miro Estruch I, Rietjens IM, Wichers HJ, Hoppenbrouwers T. In vitro methodologies to study the role of advanced glycation end products (AGEs) in neurodegeneration. Nutrients. 2022, 14:10.3390\/nu14020363","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00485","article-title":"Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis","volume":"9","author":"Juranek JK","year":"2015","unstructured":"Juranek JK, Daffu GK, Wojtkiewicz J, Lacomis D, Kofler J, Schmidt AM. Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis. Front Cell Neurosci. 2015, 9:485. 10.3389\/fncel.2015.00485","journal-title":"Front Cell Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02191-2","article-title":"Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1(G93A) murine model of amyotrophic lateral sclerosis in a sex-dependent manner","volume":"18","author":"MacLean M","year":"2021","unstructured":"MacLean M, Juranek J, Cuddapah S, et al.. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1(G93A) murine model of amyotrophic lateral sclerosis in a sex-dependent manner. J Neuroinflammation. 2021, 18:139. 10.1186\/s12974-021-02191-2","journal-title":"J Neuroinflammation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577476","article-title":"Papaverine provides neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE- NF-B pathway","volume":"352","author":"Saglam E","year":"2021","unstructured":"Saglam E, Z\u0131rh S, Aktas CC, Muftuoglu SF, Bilginer B. Papaverine provides neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE- NF-B pathway. J Neuroimmunol. 2021, 352:577476. 10.1016\/j.jneuroim.2021.577476","journal-title":"J Neuroimmunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020215","article-title":"Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology","volume":"11","author":"Snelson M","year":"2019","unstructured":"Snelson M, Coughlan MT. Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology. Nutrients. 2019, 11:10.3390\/nu11020215","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s13197-015-1851-y","article-title":"Advanced glycation end-products (AGEs): an emerging concern for processed food industries","volume":"52","author":"Sharma C","year":"2015","unstructured":"Sharma C, Kaur A, Thind SS, Singh B, Raina S. Advanced glycation end-products (AGEs): an emerging concern for processed food industries. J Food Sci Technol. 2015, 52:7561-76. 10.1007\/s13197-015-1851-y","journal-title":"J Food Sci Technol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2016.2543","article-title":"Dietary glycotoxins and infant formulas","volume":"51","author":"Kutlu T","year":"2016","unstructured":"Kutlu T. Dietary glycotoxins and infant formulas. Turk Pediatri Ars. 2016, 51:179-85. 10.5152\/TurkPediatriArs.2016.2543","journal-title":"Turk Pediatri Ars"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12850","article-title":"Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions","volume":"18","author":"Teissier T","year":"2019","unstructured":"Teissier T, Quersin V, Gnemmi V, et al.. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions. Aging Cell. 2019, 18:e12850. 10.1111\/acel.12850","journal-title":"Aging Cell"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1051\/jbio:2007025","article-title":"The metabolic, nutritional and toxicological consequences of ingested dietary Maillard reaction products: a literature review","volume":"201","author":"Tessier FJ","year":"2007","unstructured":"Tessier FJ, Niquet C. The metabolic, nutritional and toxicological consequences of ingested dietary Maillard reaction products: a literature review. J Soc Biol. 2007, 201:199-207. 10.1051\/jbio:2007025","journal-title":"J Soc Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/09637486.2015.1137889","article-title":"Dietary consumption of advanced glycation end products and risk of metabolic syndrome","volume":"67","author":"Angoorani P","year":"2016","unstructured":"Angoorani P, Ejtahed HS, Mirmiran P, Mirzaei S, Azizi F. Dietary consumption of advanced glycation end products and risk of metabolic syndrome. Int J Food Sci Nutr. 2016, 67:170-6. 10.3109\/09637486.2015.1137889","journal-title":"Int J Food Sci Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1017\/s0029665100000732","article-title":"Obesity: criteria and classification","volume":"59","author":"Pi-Sunyer FX","year":"2000","unstructured":"Pi-Sunyer FX. Obesity: criteria and classification. Proc Nutr Soc. 2000, 59:505-9. 10.1017\/s0029665100000732","journal-title":"Proc Nutr Soc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2004.013771","article-title":"Reliability and validity of a brief physical activity assessment for use by family doctors","volume":"39","author":"Marshall AL","year":"2005","unstructured":"Marshall AL, Smith BJ, Bauman AE, Kaur S. Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med. 2005, 39:294-7; discussion 294-7. 10.1136\/bjsm.2004.013771","journal-title":"Br J Sports Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1885-5857(06)60742-1","article-title":"A new IDF worldwide definition of the metabolic syndrome: of the metabolic syndrome: the rationale and the results","volume":"50","author":"Zimmet P","year":"2005","unstructured":"Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: of the metabolic syndrome: the rationale and the results. Diabetes Voice. 2005, 50:31-3. 10.1016\/S1885-5857(06)60742-1","journal-title":"Diabetes Voice"},{"key":"ref31","article-title":"Practical use of the Framingham risk score in primary prevention: Canadian perspective","volume":"57","author":"Bosomworth NJ","year":"2011","unstructured":"Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician. 2011, 57:417-423.","journal-title":"Can Fam Physician"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson PW","year":"1998","unstructured":"Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97:1837-47. 10.1161\/01.cir.97.18.1837","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100742","article-title":"Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population","volume":"35","author":"Kasim SS","year":"2023","unstructured":"Kasim SS, Ibrahim N, Malek S, et al.. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health West Pac. 2023, 35:100742. 10.1016\/j.lanwpc.2023.100742","journal-title":"Lancet Reg Health West Pac"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5543\/tkda.2011.kultursay","article-title":"Kardiyovask\u00fcler hastal\u0131k riski hesaplama y\u00f6ntemleri","volume":"39","author":"K\u00fclt\u00fcrsay H","year":"2011","unstructured":"K\u00fclt\u00fcrsay H. Kardiyovask\u00fcler hastal\u0131k riski hesaplama y\u00f6ntemleri. Arch Turk Soc Cardiol. 2011, 39:6-13. 10.5543\/tkda.2011.kultursay","journal-title":"Arch Turk Soc Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.214858","article-title":"Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: how to choose","volume":"97","author":"Tunstall-Pedoe H","year":"2011","unstructured":"Tunstall-Pedoe H. Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: how to choose. Heart. 2011, 97:442-4. 10.1136\/hrt.2010.214858","journal-title":"Heart"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jada.2010.06.096","article-title":"Assessment strategy for determining dietary advanced glycation end products","volume":"110","author":"Luevano-Contreras C","year":"2010","unstructured":"Luevano-Contreras C, Chapman-Novakofski K. Assessment strategy for determining dietary advanced glycation end products. J Am Diet Assoc. 2010, 110:27.","journal-title":"J Am Diet Assoc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality","volume":"28","author":"Chaudhuri J","year":"2018","unstructured":"Chaudhuri J, Bains Y, Guha S, et al.. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018, 28:337-52. 10.1016\/j.cmet.2018.08.014","journal-title":"Cell Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky T","year":"1997","unstructured":"Koschinsky T, He CJ, Mitsuhashi T, et al.. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A. 1997, 94:6474-9. 10.1073\/pnas.94.12.6474","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1021\/jf301306g","article-title":"1,2-dicarbonyl compounds in commonly consumed foods","volume":"60","author":"Degen J","year":"2012","unstructured":"Degen J, Hellwig M, Henle T. 1,2-dicarbonyl compounds in commonly consumed foods. J Agric Food Chem. 2012, 60:7071-9. 10.1021\/jf301306g","journal-title":"J Agric Food Chem"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1021\/jf304946p","article-title":"Metabolic transit of dietary methylglyoxal","volume":"61","author":"Degen J","year":"2013","unstructured":"Degen J, Vogel M, Richter D, Hellwig M, Henle T. Metabolic transit of dietary methylglyoxal. J Agric Food Chem. 2013, 61:10253-60. 10.1021\/jf304946p","journal-title":"J Agric Food Chem"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600140","article-title":"Quantitative assessment of organ distribution of dietary protein-bound (13) C-labeled N(\u025b) -carboxymethyllysine after a chronic oral exposure in mice","volume":"60","author":"Tessier FJ","year":"2016","unstructured":"Tessier FJ, Niquet-L\u00e9ridon C, Jacolot P, et al.. Quantitative assessment of organ distribution of dietary protein-bound (13) C-labeled N(\u025b) -carboxymethyllysine after a chronic oral exposure in mice. Mol Nutr Food Res. 2016, 60:2446-56. 10.1002\/mnfr.201600140","journal-title":"Mol Nutr Food Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201400643","article-title":"Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice","volume":"59","author":"Grossin N","year":"2015","unstructured":"Grossin N, Auger F, Niquet-Leridon C, et al.. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol Nutr Food Res. 2015, 59:927-38. 10.1002\/mnfr.201400643","journal-title":"Mol Nutr Food Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-010-0776-z","article-title":"Health effects of dietary Maillard reaction products: the results of ICARE and other studies","volume":"42","author":"Tessier FJ","year":"2012","unstructured":"Tessier FJ, Birlouez-Aragon I. Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids. 2012, 42:1119-31. 10.1007\/s00726-010-0776-z","journal-title":"Amino Acids"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4103\/hm.hm_31_22. 10.4103\/hm.hm_31_22","article-title":"Exercise, advanced glycation end products, and their effects on cardiovascular disorders: a narrative review","volume":"6","author":"Hooshiar SH","year":"2022","unstructured":"Hooshiar SH, Esmaili H, Taherian A, Jafarnejad S. Exercise, advanced glycation end products, and their effects on cardiovascular disorders: a narrative review. Heart Mind. 2022, 6:139-50. 10.4103\/hm.hm_31_22. 10.4103\/hm.hm_31_22","journal-title":"Heart Mind"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.10.004","article-title":"Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men","volume":"31","author":"Mac\u00edas-Cervantes MH","year":"2015","unstructured":"Mac\u00edas-Cervantes MH, Rodr\u00edguez-Soto JM, Uribarri J, D\u00edaz-Cisneros FJ, Cai W, Garay-Sevilla ME. Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men. Nutrition. 2015, 31:446-51. 10.1016\/j.nut.2014.10.004","journal-title":"Nutrition"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000239","article-title":"The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts forever","volume":"10","author":"DiMenna FJ","year":"2021","unstructured":"DiMenna FJ, Arad AD. The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts forever. Cardiovasc Endocrinol Metab. 2021, 10:149-61. 10.1097\/XCE.0000000000000239","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.12.089","article-title":"The receptor for advanced glycation end products (RAGE) is involved in mitochondrial function and cigarette smoke-induced oxidative stress","volume":"195","author":"Kwon OS","year":"2023","unstructured":"Kwon OS, Decker ST, Zhao J, et al.. The receptor for advanced glycation end products (RAGE) is involved in mitochondrial function and cigarette smoke-induced oxidative stress. Free Radic Biol Med. 2023, 195:261-9. 10.1016\/j.freeradbiomed.2022.12.089","journal-title":"Free Radic Biol Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1396413","article-title":"Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease","volume":"24","author":"Prasad K","year":"2015","unstructured":"Prasad K, Dhar I, Caspar-Bell G. Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease. Int J Angiol. 2015, 24:75-80. 10.1055\/s-0034-1396413","journal-title":"Int J Angiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/nu16193282","article-title":"Associations of advanced glycation end products with sleep disorders in Chinese adults","volume":"16","author":"Li L","year":"2024","unstructured":"Li L, Guo J, Liang X, et al.. Associations of advanced glycation end products with sleep disorders in Chinese adults. Nutrients. 2024, 16:10.3390\/nu16193282","journal-title":"Nutrients"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.33076\/2022.BDD.1516","article-title":"\u0130leri Glikasyon Son \u00dcr\u00fcnlerinin Diyabet Komplikasyonlar\u0131 \u00dczerine Etkileri: Bir Derleme","volume":"50","author":"Demirer B","year":"2022","unstructured":"Demirer B, Yard\u0131mc\u0131 H. \u0130leri Glikasyon Son \u00dcr\u00fcnlerinin Diyabet Komplikasyonlar\u0131 \u00dczerine Etkileri: Bir Derleme. J Nutr Diet. 2022, 50:101-8. 10.33076\/2022.BDD.1516","journal-title":"J Nutr Diet"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.03.011","article-title":"Dietary advanced glycation end products, body composition, and anthropometric measures: a cross-sectional analysis in women with excess body weight","volume":"34","author":"Mendes NP","year":"2024","unstructured":"Mendes NP, C\u00e2ndido FG, Valente FX, Peluzio MD, Juvanhol LL, Alfenas RC. Dietary advanced glycation end products, body composition, and anthropometric measures: a cross-sectional analysis in women with excess body weight. Nutr Metab Cardiovasc Dis. 2024, 34:1721-30. 10.1016\/j.numecd.2024.03.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401321","article-title":"Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)","volume":"13","author":"Tantalaki E","year":"2014","unstructured":"Tantalaki E, Piperi C, Livadas S, et al.. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones (Athens). 2014, 13:65-73. 10.1007\/BF03401321","journal-title":"Hormones (Athens)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri J","year":"2007","unstructured":"Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007, 62:427-33. 10.1093\/gerona\/62.4.427","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080152","article-title":"Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan","volume":"173","author":"Cai W","year":"2008","unstructured":"Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol. 2008, 173:327-36. 10.2353\/ajpath.2008.080152","journal-title":"Am J Pathol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-013-0574-y","article-title":"Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals","volume":"53","author":"Poulsen MW","year":"2014","unstructured":"Poulsen MW, Bak MJ, Andersen JM, et al.. Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals. Eur J Nutr. 2014, 53:661-72. 10.1007\/s00394-013-0574-y","journal-title":"Eur J Nutr"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2015.08.005","article-title":"Dietary glycemia as a determinant of health and longevity","volume":"46","author":"Whitcomb EA","year":"2015","unstructured":"Whitcomb EA, Chiu CJ, Taylor A. Dietary glycemia as a determinant of health and longevity. Mol Aspects Med. 2015, 46:14-20. 10.1016\/j.mam.2015.08.005","journal-title":"Mol Aspects Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2009.22.5.433","article-title":"HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus","volume":"22","author":"Kostolansk\u00e1 J","year":"2009","unstructured":"Kostolansk\u00e1 J, Jakus V, Bar\u00e1k L. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2009, 22:433-42. 10.1515\/jpem.2009.22.5.433","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2011.00752.x","article-title":"Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)","volume":"11","author":"Uchiki T","year":"2012","unstructured":"Uchiki T, Weikel KA, Jiao W, et al.. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell. 2012, 11:1-13. 10.1111\/j.1474-9726.2011.00752.x","journal-title":"Aging Cell"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1598183","article-title":"Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension?","volume":"26","author":"Prasad K","year":"2017","unstructured":"Prasad K, Mishra M. Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension?. Int J Angiol. 2017, 26:1-11. 10.1055\/s-0037-1598183","journal-title":"Int J Angiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3945\/jn.113.189480","article-title":"Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial","volume":"144","author":"Semba RD","year":"2014","unstructured":"Semba RD, Gebauer SK, Baer DJ, et al.. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial. J Nutr. 2014, 144:1037-42. 10.3945\/jn.113.189480","journal-title":"J Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374128-effect-of-dietary-intake-of-advanced-glycation-end-products-on-metabolic-parameters-and-anthropometric-measurements-in-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:19:44Z","timestamp":1750879184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374128-effect-of-dietary-intake-of-advanced-glycation-end-products-on-metabolic-parameters-and-anthropometric-measurements-in-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.86752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}